Loading
Latest filing published 01 Jun 2021 for Pluristem Therapeutics INC, €370k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Clover Wolf Capital - Limited Partnership is a declared insider of Pluri Inc., with filings sourced from SEC (Form 4). Between 27 May 2020 and 28 May 2021, the trades on record add up to 41 filings.
On the open market, the record shows 30 purchases worth €11.5M and 11 sales worth €3.1M. Taken together, the purchases exceed the sales by €8.4M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. So far in 2021, the count stands at no purchases and 11 sales.
In size, the median ticket on the buying side is €295k. The 30 purchases reviewed show no overlap with other insiders buying the same stock within a month.
On 1 June 2021 came the latest disclosure, an open-market sale for €217k in Pluri Inc. The latest purchase dates back some time: it was published 2,155 days ago, on 1 December 2020. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations